Epigenetics alternation in lung fibrosis and lung cancer

Epigenetics alternation in lung fibrosis and lung cancer

Respiratory disease including interstitial lung diseases (ILDs) and lung cancer is a group of devastating diseases that linked with increased morbidity and healthcare burden. However, respiratory diseases cannot be fully explained by the alternation of genetic information. Genetic studies described...

Descripció completa

Dades bibliogràfiques
Autors principals:	Xueren Li, Chunjing Feng, Shouchun Peng
Format:	Article
Idioma:	English
Publicat:	Frontiers Media S.A. 2022-11-01
Col·lecció:	Frontiers in Cell and Developmental Biology
Matèries:	epigenetics alternation DNA histone lung cancer fibrosis
Accés en línia:	https://www.frontiersin.org/articles/10.3389/fcell.2022.1060201/full

Ítems similars

Epigenetic Therapy in Lung Cancer
per: Stephen V Liu, et al.
Publicat: (2013-05-01)

Epigenetics as a versatile regulator of fibrosis
per: Yangdan Liu, et al.
Publicat: (2023-03-01)

Progress of Epigenetic Methylation in Lung Cancer Research
per: Shaowei ZHANG, et al.
Publicat: (2017-09-01)

Epigenetic mechanisms and their effects on cancer incidence and treatment: a review study
per: Reyhane Hoshyar, et al.
Publicat: (2015-07-01)

Epigenetic modification in liver fibrosis: Promising therapeutic direction with significant challenges ahead
per: Runping Liu, et al.
Publicat: (2024-03-01)

The Crosstalk Between Epigenetic Mechanisms and Alternative RNA Processing Regulation
per: Jian Zhang, et al.
Publicat: (2020-08-01)

From Bench to Bedside: Targeting Epigenetics for Cancer Therapy
per: Jin-xu Fang, et al.
Publicat: (2011-12-01)

Epigenetic features are significantly associated with alternative splicing
per: Zhou Yuanpeng, et al.
Publicat: (2012-03-01)

Mechanisms and technologies in cancer epigenetics
per: Zaki A. Sherif, et al.
Publicat: (2025-01-01)

Epigenetics in Liver Fibrosis: Could HDACs be a Therapeutic Target?
per: Alex Claveria-Cabello, et al.
Publicat: (2020-10-01)

The epigenetics of breast cancer – Opportunities for diagnostics, risk stratification and therapy
per: Rieke Schröder, et al.
Publicat: (2022-06-01)

Genome-wide DNA methylation profiling reveals novel epigenetic signatures in squamous cell lung cancer
per: Yuan-Xiang Shi, et al.
Publicat: (2017-11-01)

Natural Compounds as Epigenetic Modulators in Cancer
per: Michael Schnekenburger, et al.
Publicat: (2019-04-01)

CRC-EBD: Epigenetic Biomarker Database for Colorectal Cancer
per: Xingyun Liu, et al.
Publicat: (2020-10-01)

Role of Histone Modifications in Kidney Fibrosis
per: Shengyu Pan, et al.
Publicat: (2024-05-01)

Metformin: Sentinel of the Epigenetic Landscapes That Underlie Cell Fate and Identity
per: Javier A. Menendez
Publicat: (2020-05-01)

Epigenetic alterations in cancer
per: Suganya Ilango, et al.
Publicat: (2020-03-01)

Epigenetic Repression of Chloride Channel Accessory 2 Transcription in Cardiac Fibroblast: Implication in Cardiac Fibrosis
per: Tinghui Shao, et al.
Publicat: (2021-11-01)

Epigenetic regulation in cancer therapy: From mechanisms to clinical advances
per: Lei Tao, et al.
Publicat: (2024-03-01)

Advancement of epigenetics in stroke
per: Jianhua Peng, et al.
Publicat: (2022-10-01)

Epigenetic reprogramming in gastrointestinal cancer: biology and translational perspectives
per: Yingjie Wang, et al.
Publicat: (2024-09-01)

Epigenetics in Inflammatory Breast Cancer: Biological Features and Therapeutic Perspectives
per: Flavia Lima Costa Faldoni, et al.
Publicat: (2020-05-01)

Metabolic recoding of epigenetics in cancer
per: Yi-Ping Wang, et al.
Publicat: (2018-05-01)

Role and potential therapeutic value of histone methyltransferases in drug resistance mechanisms in lung cancer
per: Linxiang Zhang, et al.
Publicat: (2024-03-01)

DNA methylation in small cell lung cancer
per: Xianmin Zhu, et al.
Publicat: (2023-06-01)

Disruption of the expression and function of microRNAs in lung cancer as a result of epigenetic changes
per: Kousuke eWatanabe, et al.
Publicat: (2013-12-01)

Research progress and applications of epigenetic biomarkers in cancer
per: Jianjun Gao, et al.
Publicat: (2024-04-01)

Epigenetic Properties of Compounds Contained in Functional Foods Against Cancer
per: Giulia Casari, et al.
Publicat: (2024-12-01)

Reciprocal Regulation of Metabolic Reprogramming and Epigenetic Modifications in Cancer
per: Xilan Yu, et al.
Publicat: (2018-09-01)

Epigenetics in ovarian cancer: premise, properties, and perspectives
per: Qilian Yang, et al.
Publicat: (2018-07-01)

Epigenetic regulation in lung cancer
per: Shahin Ramazi, et al.
Publicat: (2023-12-01)

Epigenetic modulation of immunotherapy cofactors to enhance tumor response in lung cancer
per: Anuhya Kommalapati, et al.
Publicat: (2021-01-01)

Dietary Compounds as Epigenetic Modulating Agents in Cancer
per: Ángeles Carlos-Reyes, et al.
Publicat: (2019-03-01)

SAHA inhibits lung fibroblast activation by increasing p66Shc expression epigenetically
per: Yiheng Dong, et al.
Publicat: (2024-12-01)

Cavitating lung cancer with underlying lung fibrosis treated as case of post-COVID-19 lung fibrosis with invasive mucormycosis
per: Shital Patil, et al.
Publicat: (2022-01-01)

CANCER EPIGENETICS AND THE ROLE OF DIETARY ELEMENTS
per: Farah Abid, et al.
Publicat: (2019-09-01)

Histone Deacetylases and their Inhibitors in Cancer Epigenetics
per: Kelly N. Hassell
Publicat: (2019-11-01)

Epigenetic marvels: exploring the landscape of colorectal cancer treatment through cutting-edge epigenetic-based drug strategies
per: Azar Tahghighi, et al.
Publicat: (2025-02-01)

Epigenetic events in male common urogenital organs cancer
per: Abdelkareem A. Ahmed, et al.
Publicat: (2016-12-01)

Epigenetic therapy of cancer
per: Stankov Karmen M., et al.
Publicat: (2014-01-01)